Superficial vein thrombosis (SVT) is a relatively common condition of which the incidence was recently established to be about 0.6 per 1000 person-years (py). In the past, SVT has been considered a benign, self-limitingdisorder, requiring only symptomatic treatment. However, recent evidence showing that SVT is closely linked to occurrence of deep vein thrombosis (DVT) or pulmonary embolism (PE)...

May-Thurner syndrome (MTS) also known as Cockett's syndrome is a rare condition responsible for 2%-3% of all cases of deep venous thrombosis (DVT). The thrombosis results from mechanical compression of the left common iliac vein against the body of the fifth lumbar vertebra by the right common iliac artery. Repetitive hyperplasia of the venous wall by compression results in spur formation that ...

Modelling A decision tree model was created to capture the central issues in acute DVT treatment and to examine the costeffectiveness of fondaparinux for DVT therapy compared with enoxaparin. The model was based on various assumptions on efficacy, drug dosing and costs, which were all reported in the current study but are too numerous to be reported here. However, the authors reported that thei...

Deep vein thrombosis (DVT) is a common condition that is often under-diagnosed. Acquired or hereditary defects of coagulation or a combination of these defects may facilitate the development of DVT. Recurrent DVT, a positive family history or unusual presentation may warrant investigation for hereditary thrombophilia. Investigations are best when conducted at least one month after completion of...

Background Several case reports and studies have alluded to an increased prevalence of venous thrombosis in human immunodeficiency virus positive (HIV-positive) patients. Although a relationship between HIV infection and thrombotic disease has been suggested, the mechanisms predisposing to thrombosis have not been fully elucidated. Aim A prospective study, to determine possible coagulation fact...

Although anticoagulation therapy is the primary treatment for deep vein thrombosis (DVT), it has not been associated with the rapid recanalization of the venous occlusion. Moreover, it is associated with long-term disability due to post-thrombotic syndrome (PTS). In contrast, pharmacomechanical endovascular intervention (PMI) results in more rapid clinical improvement in DVT patients, but there...

A 42 year-old male former semi-professional soccer player sustained a right lower extremity popliteal contusion during a soccer game. He was clinically diagnosed with a possible traumatic deep vein thrombosis (DVT), and sent for confirmatory tests. A duplex doppler ultrasound was positive for DVT, and the patient was admitted to hospital for anticoagulation (unfractionated heparin, warfarin). U...

Objectives: To evaluate the efficacy and safety of single-session percutaneous mechanical thrombectomy (PMT) for deep vein thrombosis (DVT), to compare clinical outcomes recurrences between acute subacute DVT, identify factors predicting recurrence. Materials Methods: From January 2018 March 2021, 100 consecutive patients (age: 64.64 ± 17.28 years; male, 42%) with symptomatic DVT who und...

6 (2007). 28. Mueck W, Agnelli G, Buller H: Rivaroxaban has predictable pharmacokinetics (PK) and pharmacodynamics (PD) when given once or twice daily for the treatment of acute, proximal deep vein thrombosis (DVT). Blood 110, Abstract 1880 (2007).29. Agnelli G, Gallus A, Goldhaber SZ et al.; for the ODIXa-DVT Study Investigators: Treatment of proximal deep-vein thrombosis with the oral dir...

BACKGROUND Venous thromboembolism (VTE) could be manifested as deep venous thrombosis (DVT) or pulmonary embolism (PE). DVT is usually the more common manifestation and is usually formation of a thrombus in the deep veins of lower extremities. DVT could occur without known underlying cause (idiopathic thrombosis) which could be a consequence of an inherited underlying risk factor or could be a ...